D Fleming

825 total citations
16 papers, 586 citations indexed

About

D Fleming is a scholar working on Epidemiology, Infectious Diseases and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D Fleming has authored 16 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D Fleming's work include Influenza Virus Research Studies (7 papers), Respiratory viral infections research (5 papers) and Pneumonia and Respiratory Infections (4 papers). D Fleming is often cited by papers focused on Influenza Virus Research Studies (7 papers), Respiratory viral infections research (5 papers) and Pneumonia and Respiratory Infections (4 papers). D Fleming collaborates with scholars based in United Kingdom, United States and Switzerland. D Fleming's co-authors include D. J. C. Grindlay, Julia Schofield, Hywel C Williams, Sandra W. Roush, Guthrie S. Birkhead, Dongyoung Koo, Victoria J. Chalker, M. Mentasti, T. Stocki and Timothy G. Harrison and has published in prestigious journals such as JAMA, Environmental Health Perspectives and BMJ.

In The Last Decade

D Fleming

16 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Fleming United Kingdom 13 327 124 76 54 51 16 586
Adrienne Guignard Belgium 12 310 0.9× 124 1.0× 81 1.1× 26 0.5× 70 1.4× 34 569
Rudzani Muloiwa South Africa 18 411 1.3× 209 1.7× 197 2.6× 33 0.6× 38 0.7× 74 766
César Velasco Spain 16 153 0.5× 145 1.2× 33 0.4× 37 0.7× 68 1.3× 43 654
Natalie Woon Hui Tan Singapore 14 197 0.6× 425 3.4× 54 0.7× 49 0.9× 14 0.3× 39 764
Cristiano Alicino Italy 21 749 2.3× 262 2.1× 64 0.8× 10 0.2× 40 0.8× 46 1.1k
Nan-Chang Chiu Taiwan 13 259 0.8× 321 2.6× 46 0.6× 48 0.9× 6 0.1× 28 739
Rachel Herlihy United States 14 252 0.8× 267 2.2× 24 0.3× 35 0.6× 7 0.1× 29 597
Marissa M. Alejandria Philippines 10 315 1.0× 195 1.6× 21 0.3× 19 0.4× 44 0.9× 36 706
Ahmet Çağkan İnkaya Türkiye 17 155 0.5× 433 3.5× 23 0.3× 71 1.3× 11 0.2× 97 793
Ivelina Yonova United Kingdom 14 525 1.6× 135 1.1× 12 0.2× 22 0.4× 19 0.4× 34 742

Countries citing papers authored by D Fleming

Since Specialization
Citations

This map shows the geographic impact of D Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Fleming more than expected).

Fields of papers citing papers by D Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Fleming. The network helps show where D Fleming may publish in the future.

Co-authorship network of co-authors of D Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of D Fleming. A scholar is included among the top collaborators of D Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Fleming. D Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Kulke, Michael, Dieter Hörsch, M. Caplin, et al.. (2015). 37LBA Telotristat etiprate is effective in treating patients with carcinoid syndrome that is inadequately controlled by somatostatin analog therapy (the phase 3 TELESTAR clinical trial). European Journal of Cancer. 51. S728–S728. 15 indexed citations
3.
Lusignan, Simon de, Craig Kuziemsky, Freda Mold, et al.. (2014). Big Data Usage Patterns in the Health Care Domain: A Use Case Driven Approach Applied to the Assessment of Vaccination Benefits and Risks. Yearbook of Medical Informatics. 23(1). 27–35. 27 indexed citations
4.
5.
Andrews, Nick, Jim McMenamin, H Durnall, et al.. (2014). Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Eurosurveillance. 19(27). 5–13. 44 indexed citations
6.
Rosenstock, Julio, Jorge Luiz Gross, Carlos A. Aguilar‐Salinas, et al.. (2013). Long‐term 4‐year safety of saxagliptin in drug‐naive and metformin‐treated patients with Type 2 diabetes. Diabetic Medicine. 30(12). 1472–1476. 28 indexed citations
7.
Rozenbaum, Mark H., et al.. (2012). Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ. 345(oct26 1). e6879–e6879. 61 indexed citations
8.
Chalker, Victoria J., T. Stocki, M. Mentasti, et al.. (2011). Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales. European Journal of Clinical Microbiology & Infectious Diseases. 30(7). 915–921. 25 indexed citations
9.
Schofield, Julia, D Fleming, D. J. C. Grindlay, & Hywel C Williams. (2011). Skin conditions are the commonest new reason people present to general practitioners in England and Wales. British Journal of Dermatology. 165(5). 1044–1050. 100 indexed citations
10.
Chalker, Victoria J., T. Stocki, M. Mentasti, D Fleming, & Timothy G. Harrison. (2011). Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Eurosurveillance. 16(19). 40 indexed citations
11.
Fleming, D, Sally Harcourt, & Garrett Smith. (2003). Influenza and adult hospital admissions for respiratory conditions in England 1989-2001.. PubMed. 6(3). 231–7. 25 indexed citations
12.
Lambkin‐Williams, Rob, John Oxford, Biao Li, Ali A. Al‐Jabri, & D Fleming. (2000). Rapid antibody response to influenza vaccination in “at risk” groups. Vaccine. 18(21). 2307–2311. 10 indexed citations
13.
Woodhead, Mark, Daniel Lavanchy, Stephen S. Johnston, Peter M. Colman, & D Fleming. (2000). NEURAMINIDASE INHIBITORS: PROGRESS IN THE MANAGEMENT OF INFLUENZA. International Journal of Clinical Practice. 54(9). 604–610. 1 indexed citations
14.
15.
Roush, Sandra W., et al.. (1999). Mandatory Reporting of Diseases and Conditions by Health Care Professionals and Laboratories. JAMA. 282(2). 164–164. 97 indexed citations
16.
Ayres, J G, D Fleming, Martin Williams, & Gordon T. McInnes. (1989). Measurement of respiratory morbidity in general practice in the United Kingdom during the acid transport event of January 1985.. Environmental Health Perspectives. 79. 83–88. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adrienne Guignard Breakdown of academic impact, for papers by Rudzani Muloiwa Breakdown of academic impact, for papers by César Velasco Breakdown of academic impact, for papers by Natalie Woon Hui Tan Breakdown of academic impact, for papers by Cristiano Alicino Breakdown of academic impact, for papers by Nan-Chang Chiu Breakdown of academic impact, for papers by Rachel Herlihy Breakdown of academic impact, for papers by Marissa M. Alejandria Breakdown of academic impact, for papers by Ahmet Çağkan İnkaya Breakdown of academic impact, for papers by Ivelina Yonova
Rankless by CCL
2026